Luc Sterkman MD

Luc Sterkman, MD obtained his medical degree (MD) in 1988 at the Free University, Amsterdam. He has broad experience in the fields of general management, BD and R&D. From 1992-2002 he was COO and later CEO of U-Gene Research, a European CRO, which was sold to Kendle USA. From 2002 to 2010, he was Board member of the biotech company OctoPlus and later GM at the pharmaceutical company Disphar International, part of the Nordic Group. From 2011-2016 he was COO at Newtricious, a company focusing on innovative nutrition and functional foods. As CEO at Caelus Health, he is since January 2016 responsible for directing the company in the next phase of growth and further expanding its pipeline of new microbiota-based products in the field of cardio-metabolic diseases.